Title : Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.

Pub. Date : 2005 Jun 20

PMID : 15928663






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Urinary VEGF was affected by Suramin at doses above 50 mg ml(-1), corresponding to the estimated threshold of saturation of Suramin binding to urine albumin. Suramin vascular endothelial growth factor A Homo sapiens
2 Urinary VEGF was affected by Suramin at doses above 50 mg ml(-1), corresponding to the estimated threshold of saturation of Suramin binding to urine albumin. Suramin vascular endothelial growth factor A Homo sapiens